Canadian Government Partners with OmniaBio to Expand Facility at McMaster Innovation Park

Hot Topics

Favicon Logo

Hamilton Business Review

April 2, 2025
McMaster Innovation Park building.

“The Government of Canada is working tirelessly to build up Canada’s life sciences and biomanufacturing sector to develop safe and effective next-generation treatments. Since March 2020, over $2.3 billion has been invested to rebuild Canada’s vaccines, therapeutics and biomanufacturing capacity across our country.

Today, the Honourable Anita Anand, Minister of Innovation, Science and Industry, announced that Canada will work with OmniaBio to expand its facility to manufacture cell and gene therapies and provide production services to companies around the world, strengthening Canada’s participation in global value chains. Cell and gene therapies have the potential to revolutionize the treatment of a broad range of life-threatening diseases.

OmniaBio’s project will be focusing primarily on advanced treatments for chronic diseases, including cancer, autoimmune conditions, diabetes, and cardiovascular and neurological diseases. OmniaBio is seeking to expand its current space at the McMaster Innovation Park facility in Hamilton, Ontario, and invest in artificial intelligence- and robotics-enabled clinical and commercial scale manufacturing.”

See what's possible. Bring your discovery to market.

Let Invest Hamilton support you on your path to commercialization.

Name(Required)
Email(Required)

Related Articles

Related

Porter Airlines lands in Hamilton

"Porter Airlines is bringing significant new air service to Hamilton, with four routes launching in June. John C. Munro Hamilton International Airport (YHM) will be connected coast to coast through daily flights to Calgary (YYC), Edmonton (YEG), Halifax (YHZ) and...

read more